ArticleMaterials today. Bio2022

Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer.

Amirreza Mansoori-Kermani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.